Showing results (21-30 of 25) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The Lancet. Oncology|October 24, 2023
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trialSun Young Rha, Do-Youn Oh, Patricio Yañez, et al.The Lancet. Oncology|December 22, 2023
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 studyKohei Shitara, Sun Young Rha, Lucjan S Wyrwicz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2020
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal CancerTakashi Kojima, Manish A Shah, Kei Muro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2025
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 StudyKohei Shitara, Sylvie Lorenzen, Jin Li, et al.International Journal of Ophthalmology|July 22, 2017
An international survey of classification and treatment choices for group D retinoblastomaChristina Scelfo, Jasmine H Francis, Vikas Khetan, et al.Pageof 3